Fiduciary Group LLC Pfizer Inc Transaction History

Fiduciary Group LLC

  • $918 Million
  • Q2 2024

A detailed history of Fiduciary Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fiduciary Group LLC holds 93,616 shares of PFE stock, worth $2.67 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
93,616
Previous 101,082 7.39%
Holding current value
$2.67 Million
Previous $2.81 Million 6.63%
% of portfolio
0.29%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$25.26 - $29.6 $188,591 - $220,993
-7,466 Reduced 7.39%
93,616 $2.62 Million
Q1 2024

May 13, 2024
SELL
$25.89 - $29.73 $125,307 - $143,893
-4,840 Reduced 4.57%
101,082 $2.81 Million
Q4 2023

Feb 05, 2024
SELL
$26.13 - $33.94 $2.88 Million - $3.74 Million
-110,301 Reduced 51.01%
105,922 $3.05 Million
Q3 2023

Nov 13, 2023
SELL
$32.09 - $37.51 $565,875 - $661,451
-17,634 Reduced 7.54%
216,223 $7.17 Million
Q2 2023

Jul 27, 2023
SELL
$36.12 - $41.79 $276,245 - $319,609
-7,648 Reduced 3.17%
233,857 $8.58 Million
Q1 2023

May 15, 2023
SELL
$39.39 - $51.28 $299,482 - $389,881
-7,603 Reduced 3.05%
241,505 $9.85 Million
Q1 2023

May 15, 2023
SELL
$39.39 - $51.28 $177,136 - $230,606
-4,497 Reduced 1.86%
237,008 $9.67 Million
Q4 2022

Feb 07, 2023
SELL
$41.75 - $54.5 $290,955 - $379,810
-6,969 Reduced 2.72%
249,108 $12.8 Million
Q3 2022

Nov 14, 2022
SELL
$43.76 - $53.42 $31,769 - $38,782
-726 Reduced 0.28%
256,077 $12.1 Million
Q2 2022

Aug 12, 2022
SELL
$46.53 - $55.17 $157,178 - $186,364
-3,378 Reduced 1.3%
256,803 $13.5 Million
Q1 2022

May 13, 2022
BUY
$45.75 - $56.69 $311,740 - $386,285
6,814 Added 2.69%
260,181 $12.9 Million
Q4 2021

Feb 14, 2022
SELL
$41.32 - $61.25 $45,741 - $67,803
-1,107 Reduced 0.44%
253,367 $15 Million
Q3 2021

Oct 27, 2021
BUY
$39.25 - $50.42 $57,265 - $73,562
1,459 Added 0.58%
254,474 $11.1 Million
Q2 2021

Aug 05, 2021
BUY
$35.91 - $40.68 $49,663 - $56,260
1,383 Added 0.55%
253,015 $11.4 Million
Q1 2021

May 03, 2021
BUY
$33.49 - $37.77 $98,393 - $110,968
2,938 Added 1.18%
251,632 $9.73 Million
Q4 2020

Feb 12, 2021
BUY
$33.47 - $42.56 $162,865 - $207,096
4,866 Added 2.0%
248,694 $8.56 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $30,734 - $36,058
-968 Reduced 0.4%
243,828 $8.95 Million
Q2 2020

Aug 14, 2020
BUY
$30.12 - $36.54 $144,937 - $175,830
4,812 Added 2.01%
244,796 $8.01 Million
Q1 2020

May 11, 2020
BUY
$27.03 - $38.62 $368,932 - $527,124
13,649 Added 6.03%
239,984 $7.83 Million
Q4 2019

Feb 14, 2020
BUY
$32.92 - $37.36 $632,129 - $717,386
19,202 Added 9.27%
226,335 $8.87 Million
Q3 2019

Nov 13, 2019
BUY
$32.49 - $42.13 $338,643 - $439,120
10,423 Added 5.3%
207,133 $7.06 Million
Q2 2019

Aug 05, 2019
BUY
$36.98 - $41.52 $210,822 - $236,705
5,701 Added 2.98%
196,710 $8.52 Million
Q1 2019

May 08, 2019
BUY
$37.5 - $41.2 $78,187 - $85,902
2,085 Added 1.1%
191,009 $8.11 Million
Q4 2018

Feb 13, 2019
BUY
$38.47 - $43.86 $241,745 - $275,616
6,284 Added 3.44%
188,924 $8.25 Million
Q3 2018

Oct 18, 2018
BUY
$34.47 - $41.81 $50,464 - $61,209
1,464 Added 0.81%
182,640 $8.05 Million
Q2 2018

Aug 02, 2018
BUY
$32.98 - $35.16 $10,619 - $11,321
322 Added 0.18%
181,176 $6.57 Million
Q1 2018

May 14, 2018
BUY
$31.91 - $37.02 $278,574 - $323,184
8,730 Added 5.07%
180,854 $6.42 Million
Q4 2017

Feb 02, 2018
SELL
$33.26 - $35.29 $80,888 - $85,825
-2,432 Reduced 1.39%
172,124 $6.23 Million
Q3 2017

Nov 13, 2017
BUY
$31.0 - $34.15 $5.41 Million - $5.96 Million
174,556
174,556 $6.23 Million

Others Institutions Holding PFE

# of Institutions
3,222
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email